Finepoint Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Finepoint Capital’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$22M	Sell
2023 Q1	$18.7M	Sell
2022 Q4	$17.3M	Buy
2022 Q3	$18.2M	Sell
2022 Q2	$14.4M	Buy